| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1044.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
IIbß3 (GPIIb/IIIa) and
vß3 Receptors Are Not Protected From Atherosclerosis
From the Institute of Thrombosis and Hemostasis (O.S., U.S.), Laboratory of Vascular Surgery (I.R., R.V.), and the Branco and Eva Weiss Institute of Lipid and Atherosclerosis Research (D.H.), Sheba Medical Center, Tel-Hashomer, Israel; the Epidemiology Ultrasound Research Laboratory, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa (K.S., K.S.T.); and the Department of Medicine, Mount Sinai Hospital, New York, NY (B.C.).
Correspondence to Uri Seligsohn, MD, Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel 52621. E-mail seligson{at}sheba.health.gov.il
Background Platelets have been suggested to play a role in the early development of atherosclerosis. As one test of this hypothesis, we assessed whether patients with Glanzmann thrombasthenia who lack platelet glycoprotein
IIbß3 (GPIIb/IIIa) complexes or both
IIbß3 and the more ubiquitous
vß3 cell membrane complexes are protected from development of atherosclerosis.
Methods and Results Seven patients with Glanzmann thrombasthenia, 45 to 66 years of age, underwent bilateral carotid artery ultrasonography and screening for risk factors of atherosclerosis. Findings consistent with early atherosclerosis evaluated by measurement of intima-media thickness and presence of atherosclerotic plaques were observed in 6 of the 7 patients. Intima-media thickness values higher than the 75th and 90th percentiles of age- and sex-matched white control subjects of the Atherosclerosis Risk in Communities (ARIC) study were observed in 30 and 8 of 56 carotid artery measurements, respectively. Five of the 6 patients with signs consistent with early atherosclerosis lacked both
IIbß3 and
vß3 complexes and 1 only lacked
IIbß3.
Conclusions Glanzmann thrombasthenia does not protect affected individuals from development of atherosclerosis.
Key Words: atherosclerosis carotid arteries imaging platelets
This article has been cited by other articles:
![]() |
O. Salomon, D. M. Steinberg, N. Koren-Morag, D. Tanne, and U. Seligsohn Reduced incidence of ischemic stroke in patients with severe factor XI deficiency Blood, April 15, 2008; 111(8): 4113 - 4117. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gailani and T. Renne Intrinsic Pathway of Coagulation and Arterial Thrombosis Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2507 - 2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Casati, A. D'Angelo, L. Barbato, E. Rossi, M. A. Grasso, S. Spagnolo, and E. Panzeri Perioperative management of a heterozygous carrier of Glanzmann's thrombasthenia submitted to coronary artery bypass grafting with cardiopulmonary bypass. Anesth. Analg., August 1, 2006; 103(2): 309 - 11, table of contents. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Weng, L. Zemany, K. N. Standley, D. V. Novack, M. La Regina, C. Bernal-Mizrachi, T. Coleman, and C. F. Semenkovich {beta}3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice PNAS, May 27, 2003; 100(11): 6730 - 6735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sajid, K. V. Vijayan, S. Souza, and P. F. Bray PlA Polymorphism of Integrin {beta}3 Differentially Modulates Cellular Migration on Extracellular Matrix Proteins Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1984 - 1989. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |